Biological Controls and Standards for the Study and Control of Infectious Diseases
Author:
Minor Philip David
Reference21 articles.
1. Mattiuzzo G, Bentley EM, Page M (2019) The role of reference materials in the research and development of diagnostic tools and treatments for haemorrhagic fever viruses. Viruses 11:781. https://doi.org/10.3390/v11090781
2. https://nibsc.org
3. www.bipm.org
4. Zhu F-C, Li Y-H, Guan X-H et al (2020) Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 395(10240):1845–1854. https://doi.org/10.1016/S0140-6736(20)31208-3
5. Mulligan MJ, Lyke KE, Kitchin N et al (2020) Phase 1/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: interim report. Nature. https://doi.org/10.1038/s41586-020-2639-4